News

21 Minutes
News

Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant Staphylococcus aureus USA300

1. Introduction Skin and soft tissue infections (SSTIs) of healthy skin (primary infection), damaged skin (secondary infection), and/or underlying fat, fascia, and muscle are the most common infections encountered in community or healthcare settings...
Read More